Evidence check: Insulin in the context of Darmgesundheit

The question of insulin in the context of gut health is scientifically relevant, but the available information from the MyBody-X context is limited. Insulin is a key hormone in glucose metabolism, and there is growing evidence of a bidirectional relationship between the gut microbiota and insulin sensitivity. Studies indicate that a disrupted gut barrier (leaky gut) and dysbiosis can contribute to chronic inflammation, which in turn promotes insulin resistance. However, most commercial microbiome tests, such as those offered by MyBody-X, only measure the relative abundance of bacterial species, not functional parameters like insulin levels or inflammatory markers. The evidence for direct causal links between specific bacterial strains and insulin resistance is still largely mechanistic or derived from animal studies. Human studies show moderate associations, but no clinically validated cut-offs exist. Therefore, a standalone microbiome analysis without accompanying blood tests (fasting insulin, HOMA-IR) and medical interpretation is not suitable for diagnosing or managing insulin issues. Caution: Do not start any supplementation or diet based solely on a home test without consulting a physician. Evidence grade: mechanistic/human-moderate.